Physician

Josef Edrik Keith Abiog Bautista, MD

According to 2025 Medicare claims, Josef Bautista, MD (NPI: 1700131125) practices nephrology in the Everett, WA market, with the plurality of this provider's patient population coming from Snohomish, WA. This provider's primary affiliated billing organization is SNOKIDNEY PLLC (NPI: 1528810843; TIN: 992175183) and primary practice location at 98201-3564. Bautista is affiliated with the Health Connect Partners, LLC (ACO ID: A2342) and Sound Physicians Long Term Care Management, LLC (ACO ID: A5220), participating under the MSSP model.

Bautista's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 385 traditional Medicare patients, billed 2,485 HCPCS/CPT codes, and received $196,960 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,523 prescription claims across 388 beneficiaries totaling $449,063 in drug costs, led by Jardiance (Empagliflozin). DME data shows 68 claims. Open Payments data shows 3 records totaling $53. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $45,990 to $196,960. Similarly, Part D prescription costs have moved sharply higher in recent years, from $386 to $449,063. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$98K$197K2016 Medicare payment: $45,990 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $112,435 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $139,012 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $159,896 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $120,248 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $182,798 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $182,306 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $153,469 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $196,960 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016144539$45,990
20172661,640$112,435
20182872,593$139,012
20193372,155$159,896
20203691,397$120,248
20214391,387$182,798
20224511,503$182,306
20233381,238$153,469
20243852,485$196,960

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$252K$505K2015 Drug cost: $386 (USD; Tot_Drug_Cst)2016 Drug cost: $4,439 (USD; Tot_Drug_Cst)2017 Drug cost: $61,360 (USD; Tot_Drug_Cst)2018 Drug cost: $144,060 (USD; Tot_Drug_Cst)2019 Drug cost: $201,957 (USD; Tot_Drug_Cst)2020 Drug cost: $247,282 (USD; Tot_Drug_Cst)2021 Drug cost: $194,487 (USD; Tot_Drug_Cst)2022 Drug cost: $384,983 (USD; Tot_Drug_Cst)2023 Drug cost: $504,531 (USD; Tot_Drug_Cst)2024 Drug cost: $449,063 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R28$386
20163866$4,439
2017139621$61,360
20182161,367$144,060
20192791,824$201,957
20202991,809$247,282
20213141,522$194,487
20223432,038$384,983
20234032,816$504,531
20243882,523$449,063

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$385$7692021 Medicare payment: $354 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $647 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $332 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $769 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/R27$354
2022N/R44$647
2023N/R30$332
2024N/R68$769

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more129226$79
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes92251$61
99457Management using the results of remote vital sign monitoring per calendar month, first 20 minutes85199$39
99458Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes85337$31
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's135245$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
JardianceEmpagliflozin1258,780$171,461
FarxigaDapagliflozin Propanediol1237,956$134,760
LokelmaSodium Zirconium Cyclosilicate311,673$31,780
OzempicSemaglutide23952$24,523
Sevelamer CarbonateSevelamer Carbonate452,344$6,706

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R22$326
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R13$226
J7507Tacrolimus, immediate release, oral, 1 mgNN/R16$205
J7512Prednisone, immediate release or delayed release, oral, 1 mgNN/R17$13

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$53Travere Therapeutics, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Josef Edrik Keith Abiog Bautista, MD?

Tedicare shows public-source Medicare data for Josef Edrik Keith Abiog Bautista, MD (NPI 1700131125), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Josef Edrik Keith Abiog Bautista, MD have ACO affiliation data?

Josef Edrik Keith Abiog Bautista, MD is shown with ACO affiliation data for Health Connect Partners, LLC (MSSP, ACO ID A2342) and Sound Physicians Long Term Care Management, LLC (MSSP, ACO ID A5220).

What billing organization is linked to Josef Edrik Keith Abiog Bautista, MD?

Josef Edrik Keith Abiog Bautista, MD is linked to SNOKIDNEY PLLC (billing NPI 1528810843) in the available physician profile data.

Does Josef Edrik Keith Abiog Bautista, MD have Open Payments data?

Josef Edrik Keith Abiog Bautista, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.